Antibacterial drug hierarchy management: regulation of healthy drug use

With the widespread use of antibacterial drugs, the problem of bacterial resistance is growing, and the irrational use of antibacterial drugs can not only reduce the effectiveness of treatment, but can also cause serious adverse reactions and increase medical costs. In order to ensure the safe, effective and rational application of antibacterial drugs, a hierarchy of antibacterial drugs has emerged. Antibacterial drugs are classified into three levels of non-restricted use, restricted use and special use, depending on such factors as safety, efficacy, bacterial resistance and price.Non-restricted use of class-based antibacterial drugs, which have been shown to be safe and effective through long-term clinical applications, with a relatively low-cost impact on bacterial resistance. They are widely applied clinically, and general infectious diseases, such as mild respiratory infections, skin soft tissue infections, etc., are usually preferred by doctors to non-restricted antibacterial drugs. For example, common penicillin, amosilin, head acne, etc. For example, a young patient is diagnosed by a doctor as having a common cold combined with mild bronchitis because of coughing, coughing, milder symptoms, no fever and other serious discomfort. Taking into account the extent of the disease, the doctors provided them with anti-infection treatment in Amocilin. The patient ‘ s symptoms are gradually mitigated in the case of reasonable use of medicines, which is a reflection of the non-restrictive use of class-based antibacterial drugs that play an effective role in common light disease infections.Restrictions on the use of class antibacterial drugs have some limitations, or relatively high prices, in terms of efficacy, safety, effects on bacterial resistance, etc., compared to non-restricted levels of use. Such drugs are usually used to treat moderate-infective diseases or are chosen when the non-restrictive use of antibacterial drugs is ineffective. A number of second-generation septactin and some of the large ringed esters, such as PFC, Achicillin, fall into this category. For example, a middle-aged patient is hospitalized for pneumonia, with severe fever, cough and cough, and blood routines showing a marked increase in white and neutral particle cells. The doctors first used a non-restricted level of head aramid for treatment, but after three days there was no significant improvement in the patient ‘ s symptoms. At this point, the doctor, on the basis of a medical assessment, changed to a restricted use of a class of head fursync. After a period of regular treatment, the patient’s pneumonia is gradually absorbed and his condition improves. This case demonstrates that restrictions on the use of class antibacterial drugs can play an important role in cases of moderate infection and poor primary treatment. Their use requires an experienced attending and a doctor with the above title to make a prescription, and the patient ‘ s condition and drug response need to be monitored more closely during their use.The special use of a class antibacterial drug is an obvious or serious adverse reaction that is not suitable for random use; antibacterials are more effective and have a wide spectrum of antibacterials, which often or overuse results in the bacteria being too fast to produce resistance; therapeutic, safety-related clinical information is less than that of current-use drugs; and newly listed antibacterial drugs that require further examination in terms of adaptability, efficacy or safety. Specially used antibacterial drugs must be strictly controlled and are generally considered for use in cases of non-effective treatment of other antibacterials for serious infections, multi-drug-resistant infections, and combinations of infections with low immune function. Vancoma, carbon cyanide, etc. There was one patient in the intensive care ward who, due to severe abdominal infections accompanied by a variety of underlying diseases, was previously unable to control the infection using a variety of antibacterial drugs, the results of which were shown to be multi-drug-resistant infections. After an expert consultation and a detailed assessment of the patient ‘ s condition, the medical team decides to use a specific level of carbon-acrytic antibacterial drugs and to monitor closely the vital signs, liver and kidney function of the patient and infection indicators during their use. Ultimately, the patient ‘ s infection is effectively controlled, but the whole treatment process also highlights the caution and complexity of the use of specific antibacterial drugs. The prescription authority is limited to doctors with a high professional technical title, who are required to undergo an expert consultation prior to use or to have a record of the relevant difficult cases in order to ensure the reasonableness and safety of the medication.There are many important aspects to the hierarchical management of antibacterial drugs. For patients, it helps to improve the accuracy and effectiveness of treatment, to reduce the risk of adverse effects due to the irrational use of drugs and to enable the patient to recover more quickly. From the point of view of the medical system, hierarchical management facilitates the rational allocation of medical resources, avoids overuse and waste of antibacterial drugs and reduces medical costs. At the same time, it has helped to promote the development and innovation of antibacterial drugs, as the demand for new antibacterial drugs has become increasingly urgent as bacterial resistance has developed, and hierarchical management has led pharmaceutical enterprises to focus more on the development of new antibacterial drugs that are efficient, low-toxic and resistant. The hierarchical management of antibacterial drugs is an important initiative to safeguard public health and respond to the crisis of bacterial resistance. Through a reasonable hierarchy, regulated access and strict supervision, anti-bacterial drugs play the greatest role in the medical field, while keeping their risks to a minimum. Both health-care workers and ordinary patients should be deeply aware of and actively follow this management system and work together to maintain a good health environment and human health.